Jubilant receives FDA approval for antipsychotic drug

Jubilant Life Sciences LtdBSE -0.63 % today said it has received approval from the US health regulator to market generic version AstraZeneca’s Seroquel used for the treatment of schizophrenia and acute manic episodes associated with bipolar disorder.

The abbreviated new drug applications (ANDAs) approval from the US Food and Drug Administration is for Quetiapine Fumarate tablet, generic version AstraZeneca’s Seroquel is in strength of 25 mg (base).

“We expect to l ..

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s